Aerpio Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 04/15/2024
Aerpio Pharmaceuticals Stock Forecast and Price Target
If the average 2024 price target of $35.00 recently set by prominent experts for Aerpio Pharmaceuticals is met, there would be a potential upside of approximately 15.51% from the last closing price in July, 2021. The high estimate is $39.20, and the low is $31.15. If interested in ARPO stock, you may also want to consider its competitors.
15.51% Upside
Aerpio Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
Aerpio Pharmaceuticals's Price has seen growth In the last year, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $32.70 – an increase of 100.00%. For the next seven years, the forecast is forFair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$750.77 | Buy/Sell | $636.99 | 11.55% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$147.59 | Buy/Sell | $174.55 | 16.54% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$126.19 | Buy/Sell | $130.51 | 10.15% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$25.91 | Buy/Sell | $32.87 | 17.72% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$397.36 | Buy/Sell | $457.59 | 13.25% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$48.51 | Buy/Sell | $58.15 | 13.38% |
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$898.56 | Buy/Sell | $961.26 | 16.85% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$149.77 | Buy/Sell | $220.47 | 47.89% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.04 | Buy/Sell | $44.86 | 12.39% |
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$147.70 | Buy/Sell | $245.24 | 45.57% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.32 | Buy/Sell | $11.73 | 6.01% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$235.08 | Buy/Sell | $284.08 | 26.34% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$56.08 | Buy/Sell | $49.29 | 13.23% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$68.00 | Buy/Sell | $87.92 | 38.24% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$41.55 | Buy/Sell | $55.60 | 44.89% |
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$231.37 | Buy/Sell | $315.92 | 68.56% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$146.76 | Buy/Sell | $145.00 | 11.07% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.13 | Buy/Sell | $44.75 | 32.76% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$12.01 | Buy/Sell | $37.00 | 41.55% |
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$40.78 | Buy/Sell | $69.00 | 52.04% |
Aerpio Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
Aerpio Pharmaceuticals's EPS has seen growth In the last year, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that EPS will reach $0.00 – an increase of 100.00%. For the next seven years, the forecast is forEPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$14.07 | Buy/Sell | $29.44 | 141.65% |
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$23.15 | Buy/Sell | $35.67 | 64.15% |
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£15.71 | Buy/Sell | £28.89 | 100.51% |
Site Navigation
.jpg)